Bias Against People Who Inject Drugs Undermines Police Training on Needlestick Injury

door Davis, Corey S.
Gepubliceerd in Am J Public Health (2019)

Bundling occupational safety with harm reduction information as a feasible method for improving police receptiveness to syringe access programs: evidence from three U.S. cities

door Davis, Corey S, Beletsky, Leo
Gepubliceerd in 2009

Opportunities to Improve Decision-Making About Opioid Prescribing

door Rutkow, Lainie, Davis, Corey S.
Gepubliceerd in J Gen Intern Med (2016)

Opioid Policy Changes During the COVID-19 Pandemic - and Beyond

door Davis, Corey S., Samuels, Elizabeth A.
Gepubliceerd in J Addict Med (2020)

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19

door Davis, Corey S., Samuels, Elizabeth A.
Gepubliceerd in Int J Drug Policy (2021)

Chapter 18 Preserving Digital Humanities Projects Using Principles of Digital Longevity

door Huculak, J. Matthew, Davis, Corey
Gepubliceerd in 2025

Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011

door Davis, Corey S., Pierce, Matthew, Dasgupta, Nabarun
Gepubliceerd in 2014

Reducing Harm Through Litigation Against Opioid Manufacturers? Lessons From the Tobacco Wars

door Carr, Derek, Davis, Corey S., Rutkow, Lainie
Gepubliceerd in Public Health Rep (2018)

Yes, You Need a Lawyer: Integrating Legal Epidemiology Into Health Research

door Hoss, Aila, Davis, Corey S., Burris, Scott
Gepubliceerd in Public Health Rep (2020)

Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States

door Smart, Rosanna, Pardo, Bryce, Davis, Corey S.
Gepubliceerd in Addiction (2020)

The Law (and Politics) of Safe Injection Facilities in the United States

door Beletsky, Leo, Davis, Corey S., Anderson, Evan, Burris, Scott
Gepubliceerd in 2008

Overdose Epidemic, Prescription Monitoring Programs, and Public Health: A Review of State Laws

door Davis, Corey S., Johnston, Jill E., Pierce, Matthew W.
Gepubliceerd in Am J Public Health (2015)

Co-prescribing naloxone does not increase liability risk

door Davis, Corey S., Burris, Scott, Beletsky, Leo, Binswanger, Ingrid
Gepubliceerd in Subst Abus (2016)

Paraphernalia Laws, Criminalizing Possession and Distribution of Items Used to Consume Illicit Drugs, and Injection-Related Harm

door Davis, Corey S., Carr, Derek H., Samuels, Elizabeth A.
Gepubliceerd in Am J Public Health (2019)

Opioid Litigation and Maternal-Child Health–Investing in the Future

door Patrick, Stephen W., Davis, Corey S., Stein, Bradley D.
Gepubliceerd in JAMA Pediatr (2020)

Considering the Potential Benefits of Over-the-Counter Naloxone

door Evoy, Kirk E, Hill, Lucas G, Davis, Corey S
Gepubliceerd in Integr Pharm Res Pract (2021)

Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]

door Evoy, Kirk E, Hill, Lucas G, Davis, Corey S
Gepubliceerd in Integr Pharm Res Pract (2021)

Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration

door Davis, Corey S., Carr, Derek, Southwell, Jessica K., Beletsky, Leo
Gepubliceerd in Am J Public Health (2015)

Association between medical cannabis laws and opioid overdose mortality has reversed over time

door Shover, Chelsea L., Davis, Corey S., Gordon, Sanford C., Humphreys, Keith
Gepubliceerd in Proc Natl Acad Sci U S A (2019)

Opioid Prescribing Laws Are Not Associated with Short-term Declines in Prescription Opioid Distribution

door Davis, Corey S, Piper, Brian J, Gertner, Alex K, Rotter, Jason S
Gepubliceerd in Pain Med (2020)